A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)

A Prospective Study of Stapokibart Injection in Patients With SAR

This study is an open label, prospective study to evaluate the safety of Stapokibart Injection in subjects with SAR.

Inclusion Criteria:

• Participants aged 18 years or older at the time of informed consent and provide voluntary informed consent to participate in the study before inclusion in the study.
• Physician decision to treat the participant with Stapokibart Injection for SAR (according to the China-specific prescribing information) made prior to and independently of the participant's participation in the study.

Exclusion Criteria:

• Known history of allergic reaction to Stapokibart Injection.
• Participants currently or plan participating in any interventional clinical trial.
• Participants with hematologic malignancies.
• Women with pregnant.
• Any condition that, in the opinion of the Investigator, may interfere with the participant's ability to participate in the study.